By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arbor Pharmaceuticals 

980 Hammond Drive
Building Two, Suite 1250
Atlanta  Georgia  30328  U.S.A.
Phone: 866-516-4950 Fax: 678-334-2433




Company News
Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company XenoPort (XNPT) 5/23/2016 5:55:11 AM
Debiopharm International SA And Arbor Pharmaceuticals Announce Their US Commercialization Partnership For Triptorelin In Central Precocious Puberty 1/11/2016 10:31:52 AM
Wilshire Confirms First-to-File Patent Challenge Relating To LASTACAFT 12/12/2014 7:31:17 AM
KKR To Invest In Arbor Pharmaceuticals 12/5/2014 8:43:13 AM
KKR Takes Undisclosed Stake In Arbor Pharmaceuticals As Specialty Funding Heats Up 12/5/2014 8:41:51 AM
Arbor Pharmaceuticals Explores $1 Billion+ Sale 10/3/2014 6:51:16 AM
Arbor Pharmaceuticals Announces FDA Acceptance For Filing Of Its Second NDA 3/20/2014 10:28:48 AM
Takeda Pharmaceuticals, Arbor Pharmaceuticals Ink Licensing Agreement for EDARBI and EDARBYCLOR 9/13/2013 6:57:19 AM
Arbor Pharmaceuticals Announces FDA Approval of First NDA 5/14/2013 9:16:35 AM
Eisai Inc. (ESALF.PK) Divests U.S. Rights for GLIADEL® Wafer (Polifeprosan 20 With Carmustine Implant) to Arbor Pharmaceuticals 12/17/2012 9:12:38 AM